Health and Healthcare

Celgene : CELG

All CELG Articles

433 Articles

Chris Lange | Nov 11, 2015 at 7:45 AM EST

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the October 30 settlement date, and short interest fell in selected biotech stocks.

Chris Lange | Nov 4, 2015 at 1:40 PM EST

What to Expect From Celgene Earnings

Celgene is scheduled to report its third-quarter financial results before the markets open on Thursday.

Chris Lange | Oct 27, 2015 at 8:10 AM EDT

Short Sellers Become More Selective on Leading Biotechs

The October 15 short interest data have been compared with the previous figures, and short interest mixed in these selected…

Lee Jackson | Oct 20, 2015 at 10:05 AM EDT

Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now

Cowen says the way to play biotech is with large cap sector leaders that can beat earnings estimates. It also…

Lee Jackson | Oct 16, 2015 at 9:25 AM EDT

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

These three top biotech names are very good bets for investors looking to add high-quality companies with less volatility and…

Chris Lange | Oct 12, 2015 at 8:20 AM EDT

Short Sellers Increase Bets in Major Biotechs

The September 30 short interest data have been compared with the previous figures, and short interest increased in most of…

Lee Jackson | Oct 7, 2015 at 8:40 AM EDT

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

These four top large cap biotechs are very good bets for investors looking to add high-quality companies with less volatility…

Lee Jackson | Oct 5, 2015 at 10:20 AM EDT

3 Biotech Stocks Loved by Portfolio Managers Now

A new report from Cowen points out that many skittish portfolio managers are anxiously awaiting third-quarter numbers to make sure…

Jon C. Ogg | Oct 1, 2015 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: AGCO, Celgene, Devon Energy, JD.com, Microsoft, SanDisk, Crocs, Illumina and Many More

Thursday's top analyst upgrades, downgrades and initiations include AGCO, Celgene, Devon Energy, JD.com, Microsoft, SanDisk, Crocs and Illumina.

Lee Jackson | Sep 29, 2015 at 10:15 AM EDT

4 Top Jefferies Growth Stock Picks for Q4

Jefferies is basically positive overall going into earnings, and many on Wall Street are projecting a solid fourth-quarter run for…

Chris Lange | Sep 26, 2015 at 9:25 AM EDT

How the Top Biotechs Handled the Valuation Shock

24/7 Wall St. has taken a look at some of the largest biotech companies and highlighted the damage that a…

Lee Jackson | Sep 25, 2015 at 9:50 AM EDT

3 Top Jefferies Biotech Picks to Buy on Recent Sector Weakness

In a recent research report, Jefferies highlighted three top biotech companies that are very tempting buys now.

Chris Lange | Sep 25, 2015 at 8:05 AM EDT

Short Sellers Increase Bets in Major Biotech

The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks…

Lee Jackson | Sep 14, 2015 at 8:25 AM EDT

4 Top Jefferies New Growth Stock Picks to Buy Now

While Jefferies thinks the Fed waits until December to raise rates, there is always a chance it will happen this…

Lee Jackson | Sep 11, 2015 at 8:20 AM EDT

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

In a new and very comprehensive report, Jefferies starts coverage on biotechs with some very targeted stock selections.

1 … 14 15 16 17 18 … 29

Celgene : CELG

All CELG Articles

Short Sellers Run for Cover From Major Biotechs

What to Expect From Celgene Earnings

Short Sellers Become More Selective on Leading Biotechs

Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

Short Sellers Increase Bets in Major Biotechs

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

3 Biotech Stocks Loved by Portfolio Managers Now

Top Analyst Upgrades and Downgrades: AGCO, Celgene, Devon Energy, JD.com, Microsoft, SanDisk, Crocs, Illumina and Many More

4 Top Jefferies Growth Stock Picks for Q4

How the Top Biotechs Handled the Valuation Shock

3 Top Jefferies Biotech Picks to Buy on Recent Sector Weakness

Short Sellers Increase Bets in Major Biotech

4 Top Jefferies New Growth Stock Picks to Buy Now

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

Celgene : CELG

All CELG Articles

Short Sellers Run for Cover From Major Biotechs

What to Expect From Celgene Earnings

Short Sellers Become More Selective on Leading Biotechs

Q3 Worst for Biotech in 7 Years: Which Large Cap Leaders to Buy Now

Big Biotech Is Cheap With Strong Cash Flows: 3 to Buy Before Earnings

Short Sellers Increase Bets in Major Biotechs

Why Merrill Lynch Now Favors Large Cap Leaders in Biotech

3 Biotech Stocks Loved by Portfolio Managers Now

Top Analyst Upgrades and Downgrades: AGCO, Celgene, Devon Energy, JD.com, Microsoft, SanDisk, Crocs, Illumina and Many More

4 Top Jefferies Growth Stock Picks for Q4

How the Top Biotechs Handled the Valuation Shock

3 Top Jefferies Biotech Picks to Buy on Recent Sector Weakness

Short Sellers Increase Bets in Major Biotech

4 Top Jefferies New Growth Stock Picks to Buy Now

Jefferies Starts Coverage on Biotechs: 3 Top Stocks to Buy Now

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip